41
New Theories / Re: Universal Utopia? What's The Universal Terminal Goal?
« on: 15/05/2024 14:59:24 »
LEV is inching closer! Rejuvenating mitochondria - Clinical Trials
The effectiveness and efficiency of our lives will be evaluated by how much they support the continued existence of conscious entities into the future.
Quote
There are several clinical trials and research initiatives in Japan focused on drugs and therapies aimed at rejuvenating mitochondria. One notable example is the approval of Imeglimin, a first-in-class mitochondria-targeted reagent for type 2 diabetes, by a French biopharmaceutical company, Poxel SA. This drug has been approved for marketing in Japan as of 2021 and has shown favorable safety and tolerability[2]. Imeglimin targets mitochondrial function, which is crucial for its therapeutic effects in diabetes management, indirectly contributing to mitochondrial health.With LEV is approaching, we will be forced to consider our terminal goals. And sooner or later, we must align with the universal terminal goal.
Additionally, Japan is involved in various other clinical trials and research projects that explore mitochondrial rejuvenation through different mechanisms and diseases. For instance, the clinical trial registry and research initiatives often include studies on mitochondrial diseases and therapies that could potentially rejuvenate mitochondrial function. However, specific ongoing trials directly targeting mitochondrial rejuvenation in Japan were not detailed in the provided search results.
For a comprehensive understanding of all current mitochondrial rejuvenation drug trials in Japan, one would typically refer to databases like ClinicalTrials.gov or research publications from relevant Japanese research institutions and pharmaceutical companies. These sources would provide detailed information on the scope, stage, and findings of such trials.
The effectiveness and efficiency of our lives will be evaluated by how much they support the continued existence of conscious entities into the future.